ProtoKinetix, Incorporated (PKTX)
OTCMKTS · Delayed Price · Currency is USD
0.0054
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
United States Steel Market Cap
ProtoKinetix has a market cap or net worth of $2.10 million as of August 1, 2025. Its market cap has decreased by -68.21% in one year.
Market Cap
2.10M
Enterprise Value
2.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 7, 2002, ProtoKinetix's market cap has increased from 60.38K to 2.10M, an increase of 3,379.97%. That is a compound annual growth rate of 16.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 2.10M | -43.50% |
| Dec 31, 2024 | 3.72M | -43.47% |
| Dec 29, 2023 | 6.58M | -22.09% |
| Dec 30, 2022 | 8.44M | -71.61% |
| Dec 31, 2021 | 29.74M | 5.66% |
| Dec 31, 2020 | 28.15M | 12.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |